Bristol-Myers Squibb (Germany)

287.9k citations
6.0k papers ·

Impact in

  • Immunology top 2%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction
    • T-cell and B-cell Immunology
  • Oncology top 2%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research

Papers in

    • Drug Transport and Resistance Mechanisms 195
    • Cancer Immunotherapy and Biomarkers 163
    • Pharmacogenetics and Drug Metabolism 194

Bristol-Myers Squibb (Germany)

5.4k papers receiving 254.2k citations

Peers

Bristol-Myers Squibb (Germany)
Comparison fields: 5 of 238
  • Immunology 38.4k
  • Oncology 45.3k
  • Pharmaceutical Science 9.2k
  • Hematology 12.6k
  • Molecular Biology 78.4k
Replace Boehringer Ingelheim (Germany) with:
Boehringer Ingelheim (Germany) Germany
Merck KGaA, Darmstadt (Germany) Germany
Novartis Institutes for BioMedical Research Switzerland
Roche (Switzerland) Switzerland
Janssen (Belgium) Belgium
Novartis (Switzerland) Switzerland
European Institute of Oncology Italy
Fondazione IRCCS Istituto Nazionale dei Tumori Italy
Ospedale Policlinico San Martino Italy
Institute of Pharmacology Czechia
Bristol-Myers Squibb (Germany) relative to Boehringer Ingelheim (Germany) Germany Boehringer Ingelheim (Germany)'s profile →
Citations per field
00.5×2.6×
Boehringer Ingelheim (Germany) · 1×
Citations per year

Countries citing scholars working at Bristol-Myers Squibb (Germany)

Since Specialization
Citations

This map shows the geographic impact of research produced by authors working at Bristol-Myers Squibb (Germany). It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers produced at Bristol-Myers Squibb (Germany) with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bristol-Myers Squibb (Germany) more than expected).

Fields of papers published by authors at Bristol-Myers Squibb (Germany)

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers affiliated with Bristol-Myers Squibb (Germany) at the time of their publication. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers affiliated with Bristol-Myers Squibb (Germany) at the time of their publication.

About Bristol-Myers Squibb (Germany)

In recent decades, authors affiliated with Bristol-Myers Squibb (Germany) have published 6.0k papers, which have received a total of 287.9k indexed citations . Scholars at this organization have produced 1.0k papers in Oncology, 266 papers in Pharmacology, 576 papers in Immunology, 442 papers in Pharmacology and 120 papers in Virology on the topics of Monoclonal and Polyclonal Antibodies Research (320 papers), Analytical Chemistry and Chromatography (252 papers), Protein purification and stability (238 papers), HIV/AIDS drug development and treatment (220 papers), Drug Transport and Resistance Mechanisms (195 papers), Pharmacogenetics and Drug Metabolism (194 papers), Cancer Immunotherapy and Biomarkers (163 papers) and Viral Infectious Diseases and Gene Expression in Insects (152 papers). Their work is cited by papers focused on Immunology (38.4k citations), Oncology (45.3k citations), Pharmaceutical Science (9.2k citations), Hematology (12.6k citations) and Molecular Biology (78.4k citations). Authors at Bristol-Myers Squibb (Germany) collaborate with scholars in Germany, United States and Sweden and have published in prestigious journals including Bioorganic & Medicinal Chemistry Letters, The Journal of Antibiotics, Journal of Pharmaceutical Sciences, Drug Metabolism and Disposition and The Journal of Immunology. Some of Bristol-Myers Squibb (Germany)'s most productive authors include Nicholas A. Meanwell, Mariano Barbacid, Abu T.M. Serajuddin, Alejandro Aruffo, Peter S. Linsley, R Bravo, Joseph B. Bolen, Ramesh N. Patel, Mohammed Jemal and Nitin K. Damle.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore institutions with similar magnitude of impact